Home

DANIEL RAYNOR

CIK 1068854 · last filed 2018-03-19

DANIEL RAYNOR is a corporate insider who has filed 20 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider sold $439.0K of FOLD on Mar 19, 2018. Across all open-market trades the lifetime net is −$16.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $26.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$26.48M

Companies

5

Total Filings

20

Lifetime Open-Market Net

-$16.63M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ANI PHARMACEUTICALS INC (FOLD) Delisted Director 305,426 $14.49 $4.43M -$2.18M 3 2018-03-19
ANIP Director 334,292 $79.20 $26.48M -$14.45M 7 2016-04-11
ANI PHARMACEUTICALS INC (BPAX) Delisted Director — — — $0 1 2013-07-16
COMFORCE CORP (CFS) Delisted Director — — — $0 4 2010-06-18
NUCO2 INC /FL (NUCO) Delisted Director 0 — — $0 4 2008-05-29

Recent Filings

20 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-03-19 ANI PHARMACEUTICALS INC (FOLD) Delisted Sell (S) −7,215 -$439.0K EDGAR
2018-03-14 ANI PHARMACEUTICALS INC (FOLD) Delisted Sell (S) −27,964 -$1.74M EDGAR
2017-04-04 ANI PHARMACEUTICALS INC (FOLD) Delisted Grant (A) +1,000 $0 EDGAR
2016-04-11 ANIP Grant (A) +1,000 $0 EDGAR
2015-04-20 ANIP Grant (A) +800 $0 EDGAR
2015-03-16 ANIP Sell (S) −200,000 -$12.60M EDGAR
2014-03-18 ANIP Sell (S) −21,111 -$715.6K EDGAR
2014-03-18 ANIP Sell (S) −12,347 -$417.9K EDGAR
2014-03-14 ANIP Sell (S) −21,111 -$715.5K EDGAR
2013-11-14 — Mixed — $0
Showing 1–10 of 20
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.